Nicaraven

Nicaraven

SCHEMBL31420006

CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.66
MEN1 O00255 5/20 0.66
LMNA P02545 2/20 0.64
ALDH1A1 P00352 2/20 0.60
THRB P10828 1/20 0.60
KDM4E B2RXH2 1/20 0.60
HSD17B10 Q99714 1/20 0.60
ATM Q13315 1/20 0.59
EPHX2 P34913 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.52
TSHR P16473 1/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nicaraven SCHEMBL677580 1.00 KMT2A (0.66) KMT2AMEN1LMNAALDH1A1THRB
Nicaraven SCHEMBL9346555 0.96 LMNA (0.63) KMT2AMEN1LMNAALDH1A1THRB
Nicaraven SCHEMBL9345911 0.92 KMT2A (0.57) KMT2AMEN1LMNAALDH1A1THRB
Nicaraven SCHEMBL9345376 0.92 KMT2A (0.57) KMT2AMEN1LMNAALDH1A1THRB
SCHEMBL3819701 0.86 KMT2A (0.71) KMT2AMEN1LMNAALDH1A1THRB
SCHEMBL9346961 0.86 KMT2A (0.60) KMT2AMEN1LMNAALDH1A1THRB
SCHEMBL9345939 0.86 LMNA (0.55) KMT2AMEN1LMNAALDH1A1THRB
SCHEMBL24567733 0.85 LMNA (0.67) KMT2AMEN1LMNAALDH1A1THRB
SCHEMBL8722504 0.85 KMT2A (0.69) KMT2AMEN1LMNAALDH1A1THRB
SCHEMBL21467402 0.85 LMNA (0.67) KMT2AMEN1LMNAALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025034606-A2 A CLINICALLY-TRANSLATABLE ROS/RNS MOLECULAR IMAGING AGENT USING A RADIOLABELED DERIVATIVE OF EDARAVONE (EDV) ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2025-02-13 WO disclosed